These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
503 related articles for article (PubMed ID: 18408388)
21. Adiponectin as a biomarker of systemic inflammatory response in smoker patients with stable and exacerbation phases of chronic obstructive pulmonary disease. Kirdar S; Serter M; Ceylan E; Sener AG; Kavak T; Karadağ F Scand J Clin Lab Invest; 2009; 69(2):219-24. PubMed ID: 18946779 [TBL] [Abstract][Full Text] [Related]
22. Circulating visfatin in chronic obstructive pulmonary disease. Liu X; Ji Y; Chen J; Li S; Luo F Nutrition; 2009 Apr; 25(4):373-8. PubMed ID: 19056239 [TBL] [Abstract][Full Text] [Related]
23. C-reactive protein in patients with COPD, control smokers and non-smokers. Pinto-Plata VM; Müllerova H; Toso JF; Feudjo-Tepie M; Soriano JB; Vessey RS; Celli BR Thorax; 2006 Jan; 61(1):23-8. PubMed ID: 16143583 [TBL] [Abstract][Full Text] [Related]
24. [Determination and clinical implication of leukotriene B(4) and tumor necrosis factor-alpha in condensate of exhaled breath of chronic obstructive pulmonary disease patients]. Chen JL; Chen JR; Tao YJ; Cai YY; Tao GH Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 Jun; 20(6):357-60. PubMed ID: 18549718 [TBL] [Abstract][Full Text] [Related]
25. [Change of coagulation functions and its significance in acute exacerbation of chronic obstructive pulmonary disease]. Huang XX; Pang BS; Yang YH; Zhang HY; Guo SL Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(22):1543-5. PubMed ID: 21914367 [TBL] [Abstract][Full Text] [Related]
26. C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) as inflammation markers in elderly patients with stable chronic obstructive pulmonary disease (COPD). Corsonello A; Pedone C; Battaglia S; Paglino G; Bellia V; Incalzi RA Arch Gerontol Geriatr; 2011; 53(2):190-5. PubMed ID: 21074870 [TBL] [Abstract][Full Text] [Related]
27. [Systemic inflammation among stable ex smokers with chronic obstructive pulmonary disease]. Morales S A; Dreyse D J; Díaz P O; Saldías P F; Carrasco M; Lisboa B C Rev Med Chil; 2010 Aug; 138(8):957-64. PubMed ID: 21140052 [TBL] [Abstract][Full Text] [Related]
28. Association between serum C- reactive protein levels and other important predictive markers of outcome in COPD. Shameem M; Bhargava R; Ahmad Z; Saad T; Fatima N; Malik A Acta Med Iran; 2011; 49(1):18-20. PubMed ID: 21425065 [TBL] [Abstract][Full Text] [Related]
29. Levels of soluble triggering receptor expressed on myeloid cells 1 in infectious exacerbations of chronic obstructive pulmonary disease. Rohde G; Radsak MP; Borg I; Buhl R; Schultze-Werninghaus G; Taube C Respiration; 2012; 83(2):133-9. PubMed ID: 21701149 [TBL] [Abstract][Full Text] [Related]
30. Cough-reflex sensitivity to inhaled capsaicin in COPD associated with increased exacerbation frequency. Terada K; Muro S; Ohara T; Haruna A; Marumo S; Kudo M; Ogawa E; Hoshino Y; Hirai T; Niimi A; Mishima M Respirology; 2009 Nov; 14(8):1151-5. PubMed ID: 19761536 [TBL] [Abstract][Full Text] [Related]
31. Acute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levels. Wedzicha JA; Seemungal TA; MacCallum PK; Paul EA; Donaldson GC; Bhowmik A; Jeffries DJ; Meade TW Thromb Haemost; 2000 Aug; 84(2):210-5. PubMed ID: 10959691 [TBL] [Abstract][Full Text] [Related]
32. Exhaled nitric oxide, systemic inflammation, and the spirometric response to inhaled fluticasone propionate in severe chronic obstructive pulmonary disease: a prospective study. Kunisaki KM; Rice KL; Janoff EN; Rector TS; Niewoehner DE Ther Adv Respir Dis; 2008 Apr; 2(2):55-64. PubMed ID: 19124359 [TBL] [Abstract][Full Text] [Related]
33. Usefulness of C-reactive protein and interleukin-6 as predictors of outcomes in patients with chronic obstructive pulmonary disease receiving pravastatin. Lee TM; Lin MS; Chang NC Am J Cardiol; 2008 Feb; 101(4):530-5. PubMed ID: 18312772 [TBL] [Abstract][Full Text] [Related]
34. Serum biomarkers as predictors of lung function decline in chronic obstructive pulmonary disease. Higashimoto Y; Iwata T; Okada M; Satoh H; Fukuda K; Tohda Y Respir Med; 2009 Aug; 103(8):1231-8. PubMed ID: 19249197 [TBL] [Abstract][Full Text] [Related]
35. Highly elevated C-reactive protein levels in obese patients with COPD: a fat chance? Breyer MK; Spruit MA; Celis AP; Rutten EP; Janssen PP; Wouters EF; Clin Nutr; 2009 Dec; 28(6):642-7. PubMed ID: 19540024 [TBL] [Abstract][Full Text] [Related]
36. [Systemic inflammation during exacerbations of chronic obstructive pulmonary disease]. Malo O; Sauleda J; Busquets X; Miralles C; Agustí AG; Noguera A Arch Bronconeumol; 2002 Apr; 38(4):172-6. PubMed ID: 11953269 [TBL] [Abstract][Full Text] [Related]
38. Sputum bacteriology in patients with acute exacerbations of COPD in Hong Kong. Ko FW; Ng TK; Li TS; Fok JP; Chan MC; Wu AK; Hui DS Respir Med; 2005 Apr; 99(4):454-60. PubMed ID: 15763452 [TBL] [Abstract][Full Text] [Related]
39. Sputum colour reported by patients is not a reliable marker of the presence of bacteria in acute exacerbations of chronic obstructive pulmonary disease. Daniels JM; de Graaff CS; Vlaspolder F; Snijders D; Jansen HM; Boersma WG Clin Microbiol Infect; 2010 Jun; 16(6):583-8. PubMed ID: 19681947 [TBL] [Abstract][Full Text] [Related]
40. Serum amyloid a is a biomarker of acute exacerbations of chronic obstructive pulmonary disease. Bozinovski S; Hutchinson A; Thompson M; Macgregor L; Black J; Giannakis E; Karlsson AS; Silvestrini R; Smallwood D; Vlahos R; Irving LB; Anderson GP Am J Respir Crit Care Med; 2008 Feb; 177(3):269-78. PubMed ID: 18006888 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]